Ushbu ish iqtibos qilgan ishlar

257 ta ish

Ish: Eurasian guidelines for the prevention and treatment of cardiovascular diseases in patients with obesity (2022)

Comparison of optimal point on the sternum for chest compression between obese and normal weight individuals with respect to body mass index, using computer tomography: A retrospective study
Juncheol Lee, Jaehoon Oh, Tae Ho Lim +5
Maqola20182 iqtibos
ABI
Influence of BMI on inducible ventricular tachycardia and mortality in patients with myocardial infarction and left ventricular dysfunction: The obesity paradox
Rahul Samanta, Jim Pouliopoulos, Saurabh Kumar +7
Maqola20182 iqtibos
ABI
PREVEntion and regReSsive Effect of weight-loss and risk factor modification on Atrial Fibrillation: the REVERSE-AF study
Melissa E. Middeldorp, Rajeev K. Pathak, Megan Meredith +12
Maqola20182 iqtibos
ABI
An Overview and Update on Obesity and the Obesity Paradox in Cardiovascular Diseases
Andrew Elagizi, Sergey Kachur, Carl J. Lavie +4
Sharh maqola20182 iqtibos
ABI
Does body mass index truly affect mortality and cardiovascular outcomes in patients after coronary revascularization with percutaneous coronary intervention or coronary artery bypass graft? A systematic review and network meta‐analysis
Wenqi Ma, Xun Sun, Yiting Wang +3
Sharh maqola20182 iqtibos
ABI
Coronary Microvascular Dysfunction and Cardiovascular Risk in Obese Patients
Navkaranbir S. Bajaj, Michael T. Osborne, Ankur Gupta +10
Maqola20182 iqtibos
ABI
Impact of body mass index on the outcome of catheter ablation of atrial fibrillation
Benedict M. Glover, Kathryn L. Hong, Nikolaos Dagres +12
Maqola20182 iqtibos
ABI
Cardioversion of atrial fibrillation in obese patients: Results from the Cardioversion‐BMI randomized controlled trial
Aleksandr Voskoboinik, Jeremy Moskovitch, George Plunkett +15
Maqola20182 iqtibos
ABI
Safety and Effectiveness of Electrical and Pharmacological Cardioversion in Persistent Atrial Fibrillation. Part I: Study Rationale, Design and Assessment of Effectiveness
N. Yu. Mironov, V. V. Vlodzyanovskiy, Yu. A. Yuricheva +4
Maqola20182 iqtibos
ABI
Coronary Microvascular Disease Pathogenic Mechanisms and Therapeutic Options
Viviany R. Taqueti, Marcelo F. Di Carli
Sharh maqola20182 iqtibos
ABI
Reprint of: Healthy Weight and Obesity Prevention
Carl J. Lavie, Deepika Laddu, Ross Arena +3
Sharh maqola20182 iqtibos
ABI
Obesity as a Disease: The Obesity Society 2018 Position Statement
Ania M. Jastreboff, Catherine M. Kotz, Scott Kahan +2
Maqola20182 iqtibos
ABI
Lean Mass Abnormalities in Heart Failure: The Role of Sarcopenia, Sarcopenic Obesity, and Cachexia
Salvatore Carbone, Hayley Billingsley, Paula Rodriguez‐Miguelez +5
Sharh maqola20192 iqtibos
ABI
<p>Obesity paradox in cardiovascular disease: where do we stand?</p>
Salvatore Carbone, Justin M. Canada, Hayley Billingsley +3
Sharh maqola20192 iqtibos
ABI
Heart Failure Association of the European Society of Cardiology Practical Guidance on the Use of Natriuretic Peptide Concentrations
Christian Mueller, Kenneth McDonald, Rudolf A. de Boer +15
Sharh maqola20192 iqtibos
ABI
Angiotensin–Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction
Scott D. Solomon, John J.V. McMurray, Inder S. Anand +31
Maqola20192 iqtibos
ABI
Use of fenofibrate on cardiovascular outcomes in statin users with metabolic syndrome: propensity matched cohort study
Nam Hoon Kim, Ki Hoon Han, Jimi Choi +2
Maqola20192 iqtibos
ABI
Sacubitril/Valsartan Across the Spectrum of Ejection Fraction in Heart Failure
Scott D. Solomon, Muthiah Vaduganathan, Brian Claggett +22
Maqola20192 iqtibos
ABI
Optimized electrocardiographic criteria for the detection of left ventricular hypertrophy in obesity patients
Sanne M. Snelder, Sweder W.E. van de Poll, Lotte E. de Groot–de Laat +3
Maqola20202 iqtibos
ABI
AST/ALT ratio predicts the functional severity of chronic heart failure with reduced left ventricular ejection fraction
Mohammed Ewid, Hossam Sherif, Abdulaziz S. Allihimy +4
Maqola20202 iqtibos
ABI
Antihypertensive and Vasoprotective Effects of Combined Pharmacotherapy in Patients with Arterial Hypertension and Prediabetes
V. V. Skibitskiy, S. R. Gutova, А. В. Фендрикова +1
Maqola20202 iqtibos
ABI
A Randomized Trial of Intensive versus Standard Blood-Pressure Control
The SPRINT Research Group
Maqola20152 iqtibos
ABI
Supervised Obesity Reduction Trial for AF ablation patients: results from the SORT-AF trial
Nele Geßler, Stephan Willems, Daniel Steven +13
Maqola20212 iqtibos
ABI
Obesity cardiomyopathy: evidence, mechanisms, and therapeutic implications
Jun Ren, Ne N. Wu, Shuyi Wang +2
Sharh maqola20212 iqtibos
ABI
2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease
Donna K. Arnett, Roger S. Blumenthal, Michelle A. Albert +15
Maqola20192 iqtibos
ABI